Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001701478-26-000028
Filing Date
2026-05-13
Accepted
2026-05-12 20:09:09
Documents
68
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aztr-20260331.htm   iXBRL 10-Q 1262240
2 EX-31.1 aztr-2026331xexx311.htm EX-31.1 10077
3 EX-31.2 aztr-2026331xexx312.htm EX-31.2 10533
4 EX-32.1 aztr-2026331xexx321.htm EX-32.1 8643
10 GRAPHIC aztr-20260331_g1.jpg GRAPHIC 6997
11 GRAPHIC aztr-20260331_g2.jpg GRAPHIC 108075
  Complete submission text file 0001701478-26-000028.txt   7817561

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aztr-20260331.xsd EX-101.SCH 59119
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aztr-20260331_cal.xml EX-101.CAL 56853
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aztr-20260331_def.xml EX-101.DEF 261320
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aztr-20260331_lab.xml EX-101.LAB 680935
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aztr-20260331_pre.xml EX-101.PRE 475605
72 EXTRACTED XBRL INSTANCE DOCUMENT aztr-20260331_htm.xml XML 1084463
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41705 | Film No.: 26970466
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)